clinical trial · NCT07028749
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
HypertriglyceridemiaMAR001Placebo
brief summary
The primary objective of the study is to evaluate the effect of MAR001 compared to placebo on levels of the TG and RC in adults with elevated TG and RC.
started
Jun 30, 2025
primary completion
Jul 1, 2026
completion
Dec 1, 2026
last updated
Jan 26, 2026
official title
Phase 2b Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of MAR001 in Patients With Elevated Triglycerides and Remnant Cholesterol (TYDAL-TIMI 78)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol